Header Logo

The Landmark Series: Multimodality Therapy for Stage 3A Non-small Cell Lung Cancer.

The Landmark Series: Multimodality Therapy for Stage 3A Non-small Cell Lung Cancer. Ann Surg Oncol. 2020 Aug; 27(8):3030-3036.

View in: PubMed